Latest news
LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials - StocktwitsStocktwits · Fri, 07 Aug 2026 22:33:00 GMTNovo Nordisk weight-loss pill hits Germany in Sept - The Copenhagen PostThe Copenhagen Post · Thu, 06 Aug 2026 04:34:49 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTNovo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5% - CNBCCNBC · Wed, 05 Aug 2026 06:11:31 GMTNovo Nordisk Earnings Beat But Study Data, Wegovy Pill Sales Underwhelm -- Market Talk - MoomooMoomoo · Wed, 05 Aug 2026 05:53:00 GMTNovo outlook hike falls flat as Wegovy pill sales fail to impress - ReutersReuters · Tue, 04 Aug 2026 21:15:59 GMTNovo dips 6% on Wegovy pill stumble despite Q2 earnings beat - BioSpaceBioSpace · Tue, 04 Aug 2026 20:44:15 GMT